SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Gubra Outlines 2030 Strategy to Expand Clinical-Stage Pipeline

Gubra outlined a 2030 strategy focused on scaling innovation and expanding its clinical-stage pipeline.

Related stories